NEW YORK, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company ... There are numerous risks and uncertainties that may cause actual results or ...

YTD Price Performance:-99.78% Average Trading Volume: 768,940 Technical Sentiment Consensus Rating: Buy Current Market Cap: $1.29M See more insights into PBM stock on TipRanks’ Stock Analysis page.

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed” or the "Company ... There ...

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed ... with respect to future operations, products and services; and other statements identified ...

While financial assets generally were strong in the third quarter, volatility trended higher as markets continued to be ...

Good morning and thank you for joining us for the Walgreens Boots Alliance earnings call for the first quarter of fiscal year ...

The S&P 500 plunged 3% on Wednesday, Dec. 18, 2024, as the Fed cut interest rates but struck a cautious tone about future policy moves.

Walgreens Boots Alliance WBA will release its first-quarter fiscal 2024 results (ended Nov. 30) on Jan. 10 before the market ...

Concerns about cannibalization have weighed on Paycom stock over the past year, with the efficiency of its Beti automated payroll solution reportedly eating into demand for other products and ...

US stocks had a stellar performance in 2024 for the second year ... Second, Donald Trump has mentioned separating pharmacy benefits managers (PBM) from health insurers. Deutsche Bank was adamant ...